Cite
Highly Active Antiretroviral Therapy and Human Immuno-deficiency Virus—Associated Primary Cerebral Lymphoma.
MLA
Bower, Mark, et al. “Highly Active Antiretroviral Therapy and Human Immuno-Deficiency Virus—Associated Primary Cerebral Lymphoma.” JNCI: Journal of the National Cancer Institute, vol. 98, no. 15, Aug. 2006, pp. 1088–91. EBSCOhost, https://doi.org/10.1093/jnci/djj302.
APA
Bower, M., Powles, T., Nelson, M., Mandalia, S., Gazzard, B., & Stebbing, J. (2006). Highly Active Antiretroviral Therapy and Human Immuno-deficiency Virus—Associated Primary Cerebral Lymphoma. JNCI: Journal of the National Cancer Institute, 98(15), 1088–1091. https://doi.org/10.1093/jnci/djj302
Chicago
Bower, Mark, Tom Powles, Mark Nelson, Sundhiya Mandalia, Brian Gazzard, and Justin Stebbing. 2006. “Highly Active Antiretroviral Therapy and Human Immuno-Deficiency Virus—Associated Primary Cerebral Lymphoma.” JNCI: Journal of the National Cancer Institute 98 (15): 1088–91. doi:10.1093/jnci/djj302.